Summit Therapeutics SMMT
NASDAQ SMMT
$16.64 -1.19 (-6.67%)
At close: Nov 11, 2026 · 4:00 PM EST

Summit Therapeutics (SMMT) Amortization of Deferred Charges (2016 - 2020)

Updated

Analysis

Summit Therapeutics (SMMT) Amortization of Deferred Charges (2016 - 2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Summit Therapeutics 14.26 Bn 11.63 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2020 65,000.00
Dec 31, 2019 54,000.45
Oct 31, 2019 77,974.45
Jul 31, 2019 79,875.14
Mar 31, 2019 78,112.39
Jan 31, 2019 -330,000.00
Apr 30, 2018 280,342.97
Dec 23, 2017 111,563.44
Oct 31, 2017 295,947.52
Jul 31, 2017 295,000.00
Apr 30, 2017 290,000.00
Jan 31, 2017 295,000.00
Jul 31, 2016 -293,811.72
Apr 30, 2016 277,110.11
Jan 31, 2016 3.09 Mn
API Access

Summit Therapeutics Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=SMMT&period=max&api_key=YOUR_API_KEY